コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 in serum samples from patients with mild and severe acute pancreatitis.
2 elf-migrating jejunal tubes in patients with severe acute pancreatitis.
3 titis and enteral feeding and antibiotics in severe acute pancreatitis.
4 ral feeding has been strongly recommended in severe acute pancreatitis.
5 he usefulness of prophylactic antibiotics in severe acute pancreatitis.
6 leads to improved survival in patients with severe acute pancreatitis.
7 t and activin may be a therapeutic target in severe acute pancreatitis.
8 s concerning the management of patients with severe acute pancreatitis.
9 ctomy is performed sooner than 3 weeks after severe acute pancreatitis.
10 ortion of the morbidity and mortality during severe acute pancreatitis.
11 tted to the surgical ICU with a diagnosis of severe acute pancreatitis.
12 relationship of necrosis to organ failure in severe acute pancreatitis.
13 exocrine lineage-specific regeneration after severe acute pancreatitis.
14 ociated with severe hypertriglyceridemia and severe acute pancreatitis.
15 and reduced mortality rates in patients with severe acute pancreatitis.
16 ocrine regeneration after the induction of a severe acute pancreatitis.
17 ined from rats 18 hrs after the induction of severe, acute pancreatitis.
20 ections, common in patients with moderate to severe acute pancreatitis, are additionally problematic.
21 ponse genes in initiation and development of severe acute pancreatitis as a model of acute inflammati
22 BP was significantly raised in patients with severe acute pancreatitis but would seem to be of limite
23 ticular risk are those with septic shock and severe acute pancreatitis, but the adverse effects of IA
25 gative predictive values of the test to show severe acute pancreatitis compared with mild acute pancr
26 ular fluid status during the early course of severe acute pancreatitis, compared with a treatment str
27 luid resuscitation was started 2 hours after severe acute pancreatitis induction and continued for 6
28 ues of stroke volume index assessed prior to severe acute pancreatitis induction as therapeutic hemod
29 diated vasodilation before and 6 hours after severe acute pancreatitis induction, revealed less impai
32 R in 4 (2.8%) and CTRC in 2 (1.4%) patients; severe acute pancreatitis, mutation of CFTR and CTRC in
33 ) genetic, (4) autoimmune, (5) recurrent and severe acute pancreatitis, or (6) obstructive (TIGAR-O s
35 all cases of acute pancreatitis and defines "severe acute pancreatitis." Organ failure typically deve
38 sceral fat necrosis has been associated with severe acute pancreatitis (SAP) for over 100 years; howe
42 20 patients, PLR was significantly higher in severe acute pancreatitis (SAP) versus non-SAP (SMD = 1.
47 group, stroke volume index assessed prior to severe acute pancreatitis served as primary hemodynamic
48 pancreatitis, cftr (-/-) mice developed more severe acute pancreatitis than wild-type, as indicated b
51 feeding tube is often used in patients with severe acute pancreatitis to prevent gut-derived infecti
55 sensitize cftr (-/-) mice to developing more severe acute pancreatitis with an exuberant pancreatic i
56 f delaying cholecystectomy after moderate to severe acute pancreatitis with early cholecystectomy.